Formulary
Sunitinib [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Sunitinib [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Sunitinib [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Sunitinib [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Gastro-intestinal stromal tumours,Renal cell carcinoma,Pancreatic neuroendocrine tumours**
- **Adult** (By Mouth): Specialist drug - access specialist resources for dosing information.
Side effects
For sunitinib [Specialist drug] Common or very common Abscess; alopecia; anaemia; appetite decreased; arthralgia; burping; chest pain; chills; constipation; cough; dehydration; depression; diarrhoea; dizziness; dry mouth; dysphagia; dyspnoea; embolism and thrombosis; excessive tearing; eye inflammation; fatigue; fever; gastrointestinal discomfort; gastrointestinal disorders; haemorrhage; hair colour changes; headache; hypertension; hypoglycaemia; hypothyroidism; increased risk of infection; influenza like illness; insomnia; leucopenia; mucositis; muscle complaints; muscle weakness; myocardial ischaemia; nail disorder; nasal complaints; nausea; neutropenia; oedema; oral disorders; oropharyngeal pain; pain; peripheral neuropathy; proteinuria; renal impairment; respiratory disorders; sensation abnormal; sepsis; skin reactions; taste altered; thrombocytopenia; urine discolouration; vasodilation; vomiting; weight decreased Uncommon Anal fistula (interrupt treatment); cardiomyopathy; cerebrovascular insufficiency; cholecystitis; fistula (interrupt treatment); healing impaired; heart failure; hepatic disorders; hypersensitivity; hyperthyroidism; intracranial haemorrhage; myocardial infarction; osteonecrosis of jaw; pancreatitis; pancytopenia; pericardial effusion; QT interval prolongation; tumour haemorrhage Rare or very rare Angioedema; myopathy; nephrotic syndrome; posterior reversible encephalopathy syndrome (PRES); pyoderma gangrenosum; severe cutaneous adverse reactions (SCARs); thrombotic microangiopathy; thyroiditis; torsade de pointes; tumour lysis syndrome Frequency not known Aneurysm; artery dissection Side-effects, further information Heart failure, including fatal cases, has been reported; consider reducing the dose, or interrupting or stopping treatment, if symptoms of heart failure occur.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Sunitinib [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

